0.2150
-0.0020
(-0.92%)
At close: January 10 at 4:00:00 PM EST
0.2068
-0.01
(-3.81%)
After hours: 7:54:13 PM EST
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-20,691.0000
-16,108.0000
-13,965.0000
-10,368.0000
Investing Cash Flow
788.0000
10,988.0000
-631.0000
-9,164.0000
Financing Cash Flow
5,554.0000
80.0000
8,188.0000
56,563.0000
End Cash Position
915.0000
27,053.0000
32,093.0000
38,501.0000
Capital Expenditure
-635.0000
-271.0000
-633.0000
-595.0000
Issuance of Capital Stock
1,007.0000
80.0000
13,042.0000
61,248.0000
Repayment of Debt
--
--
-4,854.0000
-4,685.0000
Free Cash Flow
-21,326.0000
-16,379.0000
-14,598.0000
-10,963.0000
12/31/2020 - 7/12/1996
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
INAB IN8bio, Inc.
0.3233
+3.42%
NNVC NanoViricides, Inc.
1.3500
-2.88%
SYRS Syros Pharmaceuticals, Inc.
0.2250
+7.14%
COCP Cocrystal Pharma, Inc.
2.2100
-7.14%
IGC IGC Pharma, Inc.
0.3450
+4.12%
LYRA Lyra Therapeutics, Inc.
0.1955
-2.59%
VIRX Viracta Therapeutics, Inc.
0.1860
-0.91%
APTO Aptose Biosciences Inc.
0.2200
+3.19%
IPA ImmunoPrecise Antibodies Ltd.
0.5285
-2.85%
TSBX Turnstone Biologics Corp.
0.4802
-11.07%